Association between particular polymorphic residues on apical membrane antigen 1 (AMA-1) and platelet levels in patients with vivax malaria

Clinical Microbiology and Infection

Volumn 13, Issue 11, 2007, Pages 1089-1094

  Grynberg, P ^a   Fernandes Fontes, C J ^b   Martins Braga, E ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

Author keywords

AMA 1; Apical membrane antigen 1; Plasmodium vivax; Platelet counts; Polymorphism; Thrombocytopenia

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; SERINE; TYROSINE;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ERYTHROCYTE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MORBIDITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PARASITE PREVALENCE; PLASMODIUM VIVAX; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

PLASMODIUM VIVAX;

EID: 35148890805     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01815.x     Document Type: Article

References (23)

1. Hodder AN, Crewther PE, Matthew MLSM et al. The disulphide bond structure of Plasmodium apical membrane antigen-1. J Biol Chem 1996; 271: 29446-29452.
2. Narum DL, Thomas AW. Differential localization of full-length and processed forms of PF83/AMA-1: An apical membrane antigen of Plasmodium falciparum merozoites. Mol Biochem Parasitol 1994; 67: 59-68.
3. Mitchell GH, Thomas AW, Margos G, Dluzewski AR, Bannister LH. Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host blood cells. Infect Immun 2004; 72: 154-158.
4. Polley SD, Conway DJ. Strong diversifying selection on domains of the Plasmodium apical membrane antigen 1 gene. Genetics 2001; 158: 1505-1512.
5. Cortés A, Mellombo M, Mueller I, Benet A, Reeder JC, Anders RF. Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA-1. Infect Immun 2003; 71: 1416-1426.
6. Oh M, Shin H, Shin D et al. Clinical features of vivax malaria. Am J Trop Med Hyg 2001; 65: 143-146.
7. Wickramasinghe SN, Abdalla SH. Blood and bone marrow changes in malaria. Best Pract Res Clin Haematol 2000; 13: 277-299.
8. Kelton JG, Keystone J, Moore J et al. Immune-mediated thrombocytopenia of malaria. J Clin Invest 1983; 71: 832-836.
9. Erel O, Vural H, Aksoy N, Aslan G, Ulukanligil M. Oxidative stress of platelets and thrombocytopenia in patients with vivax malaria. Clin Biochem 2001; 34: 341-344.
10. Piguet PF, Kan CD, Vesin C. Thrombocytopenia in an animal model of malaria is associated with an increased caspase-mediated death of thrombocytes. Apoptosis 2002; 7: 91-98.
11. Monhanty D, Marwaha N, Ghosh K et al. Functional and ultrastructural changes of platelets on malaria infection. Trans R Soc Trop Med Hyg 1988; 82: 369-375.
12. Figtree M, Pasay CJ, Slade R et al. Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA1 and MSP1 genes. Mol Biochem Parasitol 2000; 108: 53-66.
13. Ewing B, Hillier L, Wendl M, Green P. Basecalling of automated sequencer traces using phred. I. Accuracy assessment. Gen Res 1998; 8: 175-185.
14. Green P. Phrap sequence assembly program, version 0. 96073. 1. Seattle: University of Washington, 1998.
15. Gordon D, Abajian C, Green P. Consed: A graphical tool for sequence finishing. Gen Res 1998; 8: 195-202.
16. Kumar S, Tamura K, Nei M. Mega3.1: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004; 5: 150-163.
17. Thompson JD, Higgings DG, Gibson TJ. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment thought sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22: 4673-4680.
18. Rozas J, Sánchez-Delbarrio JC, Messeguer X, Rozas R. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 2003; 19: 2496-2497.
19. Beale PJ, Cormack JD, Oldrey TBN. Thrombocytopenia in malaria with immunoglobulin (IgM) changes. BMJ 1972; i: 345-349.
20. Skudowitz RB, Katz J, Lirie A, Levin J, Metz J. Mechanisms of thrombocytopenia in malignant tertian malaria. BMJ 1973; ii: 515-517.
21. Bannister LH, Hopkins JM, Dluzewski AR et al. Plasmodium falciparum apical membrane antigen 1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules during merozoite development. J Cell Sci 2003; 116: 3825-3834.
22. Howell SA, Withers-Martinez C, Kocken CHM, Thomas AW, Blackman MJ. Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J Biol Chem 2001; 276: 31311-31320.
23. Coley AM, Parisi K, Masciantonio R et al. The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody. Infect Immun 2006; 74: 2628-2636.